Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome

Laczik, R.; Szodoray, P.; Veres, K.; Szomják, E.; Csípő, I.; Sipka Jr., S.; Shoenfeld, Y.; Szekanecz, Z.; Soltész, P.
June 2011
Lupus;Jun2011, Vol. 20 Issue 7, p730
Academic Journal
Objectives. Circulating IgG antibodies to oxidized low-density lipoprotein (anti-oxLDL) have been implicated in the development of atherosclerotic plaques. In this study, we investigated the prognostic value of IgG anti-oxLDL antibodies in patients with acute coronary syndrome (ACS). Methods. In total 54 patients with ACS and 41 matched healthy controls were involved in this prospective study. Serum IgG anti-oxLDL levels were assessed by ELISA. Results. Higher IgG anti-oxLDL levels were found in patients with ACS versus controls (22.8 ± 23.3 vs. 7.5 ± 5.27 EU/ml, p < 0.0001). IgG anti-oxLDL concentrations were significantly higher in ACS patients with unstable clinical complications (circulatory insufficiency, malignant arrhythmias, recurring ischaemic pain, positive stress-test, need for urgent coronary intervention or sudden cardiac death) versus those without such complications (30.0 vs. 11.7 EU/ml, p < 0.001). Twelve patients (22%) were taking statins. Patients on statins had a significant reduction in clinical complications (33%) versus patients not receiving statin therapy (61%). IgG anti-oxLDL levels were also different in these two groups (11.4 vs. 25.8 EU/ml, respectively; p = 0.03). Serum IgG anti-oxLDL levels correlated with the subsequent development of unstable coronary events. Levels of anti-oxLDL significantly decreased in response to statin therapy, independently of its lipid-lowering effect. Conclusions. Anti-oxLDL antibodies are involved in ACS. The association of anti-oxLDL with unstable clinical complications may indicate the role of this antibody in plaque destabilization.


Related Articles

  • Antioxidized LDL Antibodies Are Associated With Different Metabolic Pathways in Patients With Atherosclerotic Plaque and Type 2 Diabetes. BERNAL-LOPEZ, M. ROSA; GARRIDO-SANCHEZ, LOURDES; GOMEZ-CARRILLO, VICTOR; GALLEGO-PERALES, JOSE LUIS; LLORENTE-CORTES, VICENTA; CALLEJA, FERNANDO; GOMEZ-HUELGAS, RICARDO; BADIMON, LINA; TINAHONES, FRANCISCO J. // Diabetes Care;Apr20123, Vol. 36 Issue 4, p1006 

    OBJECTIVE--Oxidized lipoproteins and antioxidized LDL antibodies (antioxLDL abs) have been detected in human plasma and atherosclerotic lesions. The principle aimof this study was to analyze the possible relationship between IgG and IgM antioxLDL abs and factors involved in different metabolic...

  • Lipoprotein Cholesterol and Atherosclerosis. Kruth, Howard S. // Current Molecular Medicine;Dec2001, Vol. 1 Issue 6, p633 

    Progressive accumulation of cholesterol in the arterial wall causes atherosclerosis, the pathologic process underlying most heart attacks and strokes. Low density lipoprotein (LDL), the major carrier of blood cholesterol, has been implicated in the buildup of cholesterol in atherosclerotic...

  • Correlation of Oxidized Low-Density Lipoprotein and C-Reactive Protein in Patients with Coronary Artery Disease. Huang, Yuli; Wu, Yanxian; Hu, Yunzhao // Cell Biochemistry & Biophysics;Mar2013, Vol. 65 Issue 2, p285 

    A letter to the editor about the correlation of oxidized low-density lipoprotein and C-reactive protein in patients with acute coronary syndrome (ACS) is presented.

  • LDL targets lowered.  // Australian Journal of Pharmacy;Sep2012, Vol. 93 Issue 1108, p26 

    The article informs that the Low-density lipoprotein (LDL) target has been lowered down to of 2.0milimolar/liter (mmol/L) by the National Heart Foundation of Australia for the people who have already suffered a heart attack.

  • Inhibitory Effect of Three C-glycosylflavonoids from Cymbopogon citratus (Lemongrass) on Human Low Density Lipoprotein Oxidation. Orrego, Roxana; Leiva, Elba; Cheel, José // Molecules;Oct2009, Vol. 14 Issue 10, p3906 

    This study assessed the inhibitory effect of three C-glycosylflavonoids from Cymbopogon citratus leaves - isoorientin (1), swertiajaponin (2) and isoorientin 2″-Orhamnoside (3) - on human LDL oxidation. Isolated LDL was incubated with compounds 1-3 and the kinetics of lipid peroxidation...

  • A Change Of Heart About Cholesterol. AGATSTON, ARTHUR // Prevention;Aug2011, Vol. 63 Issue 8, p20 

    The article emphasizes that knowing the particle size of low-density lipoprotein (LDL) known as bad cholesterol may help determine if an individual is at risk of heart attack. Small LDL particles are likely to be harmful as they are being deposited in arterial walls and lead to the formation of...

  • Low Density Lipoprotein transport in the normal human aortic arch. Soulis, JV; Dimitrakopoulou, M; Giannoglou, GD // Hippokratia;2014, Vol. 18 Issue 3, p221 

    Background: To understand the genesis and progression of atherosclerosis is essential to elucidate the blood flow and the transport of molecules in the cardiovascular system. The purpose of this computational study is to elucidate the relationship between low wall shear stress (WSS) - high site...

  • Vitamin C and vitamin E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation. Ulrich-Merzenich, Gudrun; Metzner, Christine; Schiermeyer, Beate; Vetter, Hans // European Journal of Nutrition;2002, Vol. 41 Issue 1, p27 

    Deals with a study which examined the effect of vitamin C, E and the oxidation of low density lipoproteins on the DNA synthesis of vascular arterial endothelial and smooth muscle cells. Incubation of human umbilical arterial endothelial cells and human arterial smooth muscle cells; Impact on...

  • N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein. Cui, Yuqi; Narasimhulu, Chandrakala A.; Liu, Lingjuan; Zhang, Qingbin; Liu, Patrick Z.; Li, Xin; Xiao, Yuan; Zhang, Jia; Hao, Hong; Xie, Xiaoyun; He, Guanglong; Cui, Lianqun; Parthasarathy, Sampath; Liu, Zhenguo // Scientific Reports;11/6/2015, p16339 

    Low-density lipoprotein (LDL) is non-atherogenic, while oxidized LDL (ox-LDL) is critical to atherosclerosis. N-acetylcysteine (NAC) has anti-atherosclerotic effect with largely unknown mechanisms. The present study aimed to determine if NAC could attenuate in vivo LDL oxidation and inhibit...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics